Science Explorer Back to mapMap
Discussion
Researcher · Luye Pharma (China) · China

Changlin Dou

Changlin Dou publishes mostly in Molecular Biology, Immunology and Oncology, on topics such as Biosimilars and Bioanalytical Methods, SARS-CoV-2 and COVID-19 Research and Developmental Biology and Gene Regulation.

ORCID 0000-0001-8221-8086 OpenAlex
World rank
#3,792,546
of 7,710,434 ranked researchers
Rank in China
#591,997
of 978,568
Works
41
Citations
658
Citations per work
16.0
h-index
10
i10-index 10Top 76% in Molecular Biology
Changlin Dou

What does Changlin Dou research?

Changlin Dou's work is mostly in Biochemistry, Genetics and Molecular Biology (26%), Medicine (26%), Immunology and Microbiology (17%).

Life Sciences: 18 works · 43.1% of their workBiochemistry, Genetics and Molecular Biology: 11 works · 26.1% of their workMolecular Biology: 9 works · 21.6% of their workCell Biology: 2 works · 4.5% of their workImmunology and Microbiology: 7 works · 17.0% of their workImmunology: 7 works · 17.0% of their workEverything else: 13 works · 30.8% of their workHealth Sciences: 11 works · 26.1% of their workMedicine: 11 works · 26.1% of their workOncology: 5 works · 12.5% of their workInfectious Diseases: 4 works · 9.1% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 4.5% of their workTHEIR WORKChanglin Dou41works
Life Sciences43%Health Sciences26%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1126.1%
    2. Immunology and Microbiology717.0%
  2. Everything else1330.8%
    1. Medicine1126.1%
  1. 1Molecular Biology22% of their works
  2. 2Immunology17% of their works
  3. 3Oncology12% of their works
  4. 4Infectious Diseases9% of their works
  5. 5Cell Biology4% of their works
  6. 6Radiology, Nuclear Medicine and Imaging4% of their works

Research topics

Which keywords describe Changlin Dou's research?

The keywords of their largest research topics: Monoclonal Antibodies, Stem Cells, Biosimilars, Immunogenicity, Cancer, Development, Tumorigenesis and Coronavirus.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Monoclonal Antibodies112 topics
  2. Stem Cells93 topics
  3. Biosimilars81 topic
  4. Immunogenicity81 topic
  5. Cancer62 topics
  6. Development62 topics
  7. Tumorigenesis62 topics
  8. Coronavirus41 topic
  9. SARS-CoV-241 topic
  10. Breast Cancer31 topic
  11. Fc Receptors31 topic
  12. Gene Regulation31 topic
  13. HER231 topic
  14. Hedgehog Signaling31 topic
  15. Krüppel-like Factors31 topic
  16. Notch Signaling31 topic
  17. Pathway Inhibition31 topic
  18. Therapeutic Antibodies31 topic
  19. Transcriptional Regulation31 topic
  20. Hyaluronan21 topic
  21. Proteoglycans21 topic

Where does Changlin Dou work?

Changlin Dou's main affiliation in the publication record is Luye Pharma (China), China.

How many publications and citations does Changlin Dou have?

OpenAlex counts 41 works and 658 citations for Changlin Dou, an h-index of 10, ranking #3,792,546 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Changlin Dou. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.